Hypertension:基因表达的变化可致孕妇高血压

2012-04-16 T.Shen 生物谷

凝血恶烷合酶(Credit: Image courtesy of Virginia Commonwealth University) 近日,弗吉尼亚联邦大学医学院的研究者通过研究发现,关键酶基因表达的变化在子癫前期的怀孕妇女中可以促使高血压以及增加血块成型的敏感性。这项研究发现可以为临床上治疗孕妇高血压以及血块成型敏感性提供一些治疗线索,血块形成敏感可以阻塞血流进而导致孕妇各项内脏器官衰竭。

凝血恶烷合酶(Credit: Image courtesy of Virginia Commonwealth University)

近日,弗吉尼亚联邦大学医学院的研究者通过研究发现,关键酶基因表达的变化在子癫前期的怀孕妇女中可以促使高血压以及增加血块成型的敏感性。这项研究发现可以为临床上治疗孕妇高血压以及血块成型敏感性提供一些治疗线索,血块形成敏感可以阻塞血流进而导致孕妇各项内脏器官衰竭。

研究者研究从分子水平揭示了孕妇先兆子癫的原因,而且识别出表观遗传机制或许在起作用。表观遗传学涉及基因表达的改变,而不是DNA序列的改变。这项研究结果刊登在了国际杂志Hypertension上,研究小组报道了凝血恶烷合酶,一种重要的炎症酶,这种酶在子癫前期的孕妇血液中明显升高,编码该酶的基因也参与了很多疾病的形成,比如心血管病和中风,这种酶可以引起凝血的发生,进而增加血压促使血块形成。

“当前的研究为先兆子癫相关的表观遗传学成因提出了新的观点,而且,这也是第一项研究揭示了母体血管中表观遗传学的改变和先兆子癫有关。”研究者Scott W.Walsh表示。Walsh还说,主要的表观遗传机制是DNA的甲基化,可以控制基因的表达,血管中酶量的增加和DNA甲基化的降低直接相关,而且中性白细胞可以深入血管中,中性白细胞是帮助机体抵抗感染的白血细胞。

研究者Walsh指出,未来潜在的治疗孕妇先兆子癫的方法包括抑制凝血恶烷合酶、堵塞血栓烷受体或者在饮食中补充叶酸,叶酸的补充可以增加甲基供体以保护DNA甲基化的反向改变,从而影响凝血恶烷合酶的表达。这项研究基于研究者前期的研究,在研究者前期研究中,研究者揭示了中性白细胞作为孕妇先兆子癫的致病因子的角色。这项研究由国立健康中心支持。(生物谷:T.Shen编译)

Copyright ©版权归生物谷所有,若未得到Bioon授权,请勿转载。

doi:10.1161/​HYPERTENSIONAHA.111.188730
PMC:
PMID:

Reduced Methylation of the Thromboxane Synthase Gene Is Correlated With Its Increased Vascular Expression in Preeclampsia

Ahmad A. Mousa, Jerome F. Strauss III, Scott W. Walsh

Preeclampsia is characterized by increased thromboxane and decreased prostacyclin levels, which predate symptoms, and can explain some of the clinical manifestations of preeclampsia, including hypertension and thrombosis. In this study, we examined DNA methylation of the promoter region of the thromboxane synthase gene (TBXAS1) and the expression of thromboxane synthase in systemic blood vessels of normal pregnant and preeclamptic women. Thromboxane synthase is responsible for the synthesis of thromboxane A2, a potent vasoconstrictor and activator of platelets. We also examined the effect of experimentally induced DNA hypomethylation on the expression of thromboxane synthase in a neutrophil-like cell line (HL-60 cells) and in cultured vascular smooth muscle and endothelial cells. We found that DNA methylation of the TBXAS1 promoter was decreased and thromboxane synthase expression was increased in omental arteries of preeclamptic women as compared with normal pregnant women. Increased thromboxane synthase expression was observed in vascular smooth muscles cells, endothelial cells, and infiltrating neutrophils. Experimentally induced DNA hypomethylation only increased expression of thromboxane synthase in the neutrophil-like cell line, whereas tumor necrosis factor-α, a neutrophil product, increased its expression in cultured vascular smooth muscle cells. Our study suggests that epigenetic mechanisms and release of tumor necrosis factor-α by infiltrating neutrophils could contribute to the increased expression of thromboxane synthase in maternal systemic blood vessels, contributing to the hypertension and coagulation abnormalities associated with preeclampsia.

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2038441, encodeId=87fc2038441fc, content=<a href='/topic/show?id=b45d1e274e8' target=_blank style='color:#2F92EE;'>#TENS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17274, encryptionId=b45d1e274e8, topicName=TENS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3b172500206, createdName=12498ebem19暂无昵称, createdTime=Wed Aug 29 13:48:00 CST 2012, time=2012-08-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1725415, encodeId=82fa1e2541598, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Tue Mar 19 15:48:00 CST 2013, time=2013-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1347985, encodeId=fd6e134e9855e, content=<a href='/topic/show?id=d61b418860a' target=_blank style='color:#2F92EE;'>#基因表达#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=41886, encryptionId=d61b418860a, topicName=基因表达)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=395f25, createdName=bioon1, createdTime=Wed Apr 18 11:48:00 CST 2012, time=2012-04-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1500998, encodeId=eba115009981d, content=<a href='/topic/show?id=f2db9238f9' target=_blank style='color:#2F92EE;'>#Hypertension#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=9238, encryptionId=f2db9238f9, topicName=Hypertension)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=11ff9497046, createdName=jambiya, createdTime=Wed Apr 18 11:48:00 CST 2012, time=2012-04-18, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=2038441, encodeId=87fc2038441fc, content=<a href='/topic/show?id=b45d1e274e8' target=_blank style='color:#2F92EE;'>#TENS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17274, encryptionId=b45d1e274e8, topicName=TENS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3b172500206, createdName=12498ebem19暂无昵称, createdTime=Wed Aug 29 13:48:00 CST 2012, time=2012-08-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1725415, encodeId=82fa1e2541598, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Tue Mar 19 15:48:00 CST 2013, time=2013-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1347985, encodeId=fd6e134e9855e, content=<a href='/topic/show?id=d61b418860a' target=_blank style='color:#2F92EE;'>#基因表达#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=41886, encryptionId=d61b418860a, topicName=基因表达)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=395f25, createdName=bioon1, createdTime=Wed Apr 18 11:48:00 CST 2012, time=2012-04-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1500998, encodeId=eba115009981d, content=<a href='/topic/show?id=f2db9238f9' target=_blank style='color:#2F92EE;'>#Hypertension#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=9238, encryptionId=f2db9238f9, topicName=Hypertension)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=11ff9497046, createdName=jambiya, createdTime=Wed Apr 18 11:48:00 CST 2012, time=2012-04-18, status=1, ipAttribution=)]
    2013-03-19 feather89
  3. [GetPortalCommentsPageByObjectIdResponse(id=2038441, encodeId=87fc2038441fc, content=<a href='/topic/show?id=b45d1e274e8' target=_blank style='color:#2F92EE;'>#TENS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17274, encryptionId=b45d1e274e8, topicName=TENS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3b172500206, createdName=12498ebem19暂无昵称, createdTime=Wed Aug 29 13:48:00 CST 2012, time=2012-08-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1725415, encodeId=82fa1e2541598, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Tue Mar 19 15:48:00 CST 2013, time=2013-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1347985, encodeId=fd6e134e9855e, content=<a href='/topic/show?id=d61b418860a' target=_blank style='color:#2F92EE;'>#基因表达#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=41886, encryptionId=d61b418860a, topicName=基因表达)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=395f25, createdName=bioon1, createdTime=Wed Apr 18 11:48:00 CST 2012, time=2012-04-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1500998, encodeId=eba115009981d, content=<a href='/topic/show?id=f2db9238f9' target=_blank style='color:#2F92EE;'>#Hypertension#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=9238, encryptionId=f2db9238f9, topicName=Hypertension)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=11ff9497046, createdName=jambiya, createdTime=Wed Apr 18 11:48:00 CST 2012, time=2012-04-18, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=2038441, encodeId=87fc2038441fc, content=<a href='/topic/show?id=b45d1e274e8' target=_blank style='color:#2F92EE;'>#TENS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17274, encryptionId=b45d1e274e8, topicName=TENS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3b172500206, createdName=12498ebem19暂无昵称, createdTime=Wed Aug 29 13:48:00 CST 2012, time=2012-08-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1725415, encodeId=82fa1e2541598, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Tue Mar 19 15:48:00 CST 2013, time=2013-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1347985, encodeId=fd6e134e9855e, content=<a href='/topic/show?id=d61b418860a' target=_blank style='color:#2F92EE;'>#基因表达#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=41886, encryptionId=d61b418860a, topicName=基因表达)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=395f25, createdName=bioon1, createdTime=Wed Apr 18 11:48:00 CST 2012, time=2012-04-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1500998, encodeId=eba115009981d, content=<a href='/topic/show?id=f2db9238f9' target=_blank style='color:#2F92EE;'>#Hypertension#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=9238, encryptionId=f2db9238f9, topicName=Hypertension)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=11ff9497046, createdName=jambiya, createdTime=Wed Apr 18 11:48:00 CST 2012, time=2012-04-18, status=1, ipAttribution=)]

相关资讯

Sci Transl Med:夜节律失步为糖尿病创造条件

4月11日,根据国际著名杂志Science Translational Medicine上的一项新的研究披露,对国际旅行者、晚夜班员工或其他身体时钟失步的人来说,昼夜节律的破坏可损害身体制造胰岛素的能力,并潜在地为糖尿病的发生创造条件。这些发现帮助人们解释先前的对男性夜班工人有着较高的罹患肥胖症和糖尿病风险的研究。Orfeu Buxton及其同事们将21名实验参与者保持在受到控制的实验室环境中近乎

Cell Metab:针对胰高血糖素通路治疗糖尿病

胰岛素用于维持血液中糖在适当水平,胰岛素能清除血糖,也称为胰高血糖素。   理查德·联合在医学部的教授和研究副主席艾拉塔巴斯博士说,我们发现一种方式以减少胰高血糖素对血糖的影响,并且不带来无副作用。   在过去十年中,由于肠促胰岛素的成功,带来了有关II型糖尿病药物的胰高血糖素研究的复兴。肠促胰岛素刺激胰岛素的分泌,但最近的研究表明,肠促胰岛素的临床成功可以归结为抑制胰

PLoS Genetics:深度DNA测序技术揭露中草药的化合物成分及毒性

本研究中所用的四种中药样品:A:熊胆汁晶体 B:赛加羚羊角粉末 C:牙痛一粒丸 D:八宝清心散 近日,来自澳洲莫道克大学的研究者运用新的DNA技术来揭示动物和植物传统中药的药物组分(TCMs),一些检测中药样品中包含有一些潜在的毒性植物成分、变应原以及将要绝种的动物残痕。研究者Bunce博士表示,中药有千年的历史,但是如今,消费者在使用中药作为一种治疗策略之前,一定要清楚中药的合法性和其健康安全

Neurology:抗抑郁新药对帕金森氏症患者是安全的

星期三,4月11日(每日健康新闻)报道,近来研究人员发现一些较新的抗抑郁药可以帮助治疗帕金森氏病患者的抑郁症,不会加重帕金森氏病的其他症状如震颤或等。 近1亿美国人患帕金森氏症。帕金森氏症和抑郁症往往同时发生,以往认为一些用于治疗抑郁症的药物可能会加剧帕金森氏症。 4月17日的Neurology杂志上刊登的一则研究证实情况并非如此,至少抗抑郁药帕罗西汀(帕罗西汀)和Effexor(文拉法辛)并

J Lipid Res:郑辉等发现胆固醇水平影响受体功能

中科院广州生物医药与健康研究院郑辉博士研究组发现,在人胚胎肾细胞(HEK)、原代培养的大鼠海马区神经细胞以及成年小鼠体内,低于正常的胆固醇水平会阻碍μ型阿片受体的信号转导和其介导的镇痛作用。研究组与北京中日友好医院合作,发现病人血液总胆固醇水平与手术麻醉时使用的芬太尼的剂量成负相关。 研究表明,虽然高胆固醇水平会增加罹患心血管疾病的几率,但过低的胆固醇水平会阻碍部分G蛋白偶联受体(以μ型阿片受体

IOVS:标准视力测试能预知夜间驾驶能力吗?

已通过机动车辆管理视力测试的司机,并不意味着他或她就能安全驾驶。最近一项研究发现,中等水平视力模糊和白内障的司机夜间识别行人的频率与距离严重下降,即使司机已通过必需的视力测试。 视力模糊和白内障非常普遍,许多有这些情况的人还在继续开车。我们这项研究的目的就是更好地了解这些视力情况如何影响司机在夜间对路旁行人的识别能力和反应能力,同时也想弄清楚,着某一类型服装的行人是否能增强司机夜间的行人识别能力